Just in time for summer, the U.S. Food and Drug Administration (FDA) announced game-changing news. The FDA expanded the emergency use authorization for the Pfizer messenger RNA Covid-19 vaccine for kids ages 12–15 years old.
The Pfizer-BioNTech Covid-19 vaccine met the FDA’s safety and efficacy criteria to expand the emergency use authorization. Until now, the Pfizer vaccine was approved for use in people 16 years and older.
Pfizer previously announced in a press release highly encouraging results from their phase 3 clinical trial. The Pfizer-BioNTech Covid-19 vaccine was 100% effective and generated a high antibody response in children ages 12–15.
With adult vaccinations against Covid-19 well underway in the U.S., attention is turning to pediatric vaccines for children under the age of 16.
I sat down with three pediatric and vaccination specialists from Mayo Clinic — Robert Jacobson, MD, Nipunie Rajapakse, MD, MPH, and Joseph Poterucha, DO — to get answers to some of the most common questions around children and Covid-19 vaccines.
Yes. “We definitely will need vaccines for children against Covid-19 infection,” says Jacobson. “While rates and severity of infection are lower in children, children do still spread the infection and occasionally develop severe disease.”
Compared to adults…
A case study in Ohio revealed this week illustrates how one person at an indoor gathering can spark dozens of Covid-19 cases, including the infections of several children who go on to infect others.
At a church event in Ohio, the single case branched out from the initial transmissions in the church, shown in blue in the graphic above, to at least 33 secondary cases beyond the event and at least five third-level cases, according to the Ohio Department of Health.
Five of the initial infections that occurred in the church were among children or teens, including a 6-year-old who…
A blog from Medium for Covid-19 news, advice, and commentary.